Traitement Préventif VIH Ipergay, They were expected. The results of the Ipergay clinical trial were presented Tuesday, February 24, at the 22nd Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. They demonstrate a very high efficiency (86%) of a "pre-exposure prophylaxis" (PrEP) taken at the request in a population at high ..
Continue Reading...
No comments:
Post a Comment